Global Anti-obesity Medicine Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

Extent Research has published a new report on the “Global Anti-obesity Medicine Market: 2026”. The published report includes all the important attributes of the Anti-obesity Medicine market, such as market dynamics, market segmentation, market growth rate, and the competitive landscape among the industry players. The market segmentation that is included in the Anti-obesity Medicine market research study are by Application Men, Women, , by Product type Prescription Drugs, OTC Drugs, . The list of the major players that are incorporated in the report are Alizyme, Amylin Pharmaceuticals, Arena Pharmaceuticals, Boehringer Ingelheim, Eisai, GlaxoSmithKline, Orexigen Therapeutics, Vivus, Pfizer, Roche, Merck, Novo Nordisk, .

Data provided by Extent Research. Source: https://www.extentresearch.com/anti-obesity-medicine-market

The regional analysis that this report covers about the key regions includes sales, revenue, market share, and growth rate of the Anti-obesity Medicine market in these regions. (Timeline from 2015 to 2036)

North America (United States, Canada, and Mexico)
Europe (Germany, UK, and France)
Asia-Pacific (China, Japan, Korea, India, and Australia)
South America (Brazil, Argentina, and Columbia)
Middle East and Africa (Saudi Arabia, UAE, and South Africa)

This Anti-obesity Medicine Market Research Report Offers Solutions for the following Questions

Which manufacturing technology is used for Anti-obesity Medicine? What are the developments in that technology? Which trends have led to these developments?
Who are the global key players functioning in the Anti-obesity Medicine market? What are their company profiles, product portfolio, and other important data?
What was global market status? What were the production value, cost, and profit margins of the Anti-obesity Medicine market?
What is current market status of the Anti-obesity Medicine industry? What is the market competition in this business?
What are projections of global Anti-obesity Medicine industry considering capacity, production, and production value? What will be the anticipated cost and profit? What will be market share, supply and consumption? What are the import and export details?
What is the Anti-obesity Medicine market chain analysis by upstream raw materials and downstream industry?
What is the economic impact of COVID-19 on the Anti-obesity Medicine industry? What are global macroeconomic environment analysis results?
What are the Anti-obesity Medicine market dynamics? What are the challenges and opportunities?
What should be entry strategies, countermeasures to economic impact, and marketing channels for Anti-obesity Medicine industry?

Report Scope and Market Segmentation

ATTRIBUTES	Global Anti-obesity Medicine Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Anti-obesity Medicine Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Anti-obesity Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Prescription Drugs
        1.2.3 OTC Drugs
    1.3 Market by Application
        1.3.1 Global Anti-obesity Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Men
        1.3.3 Women
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Anti-obesity Medicine Market Perspective (2017-2035)
    2.2 Anti-obesity Medicine Growth Trends by Region
        2.2.1 Anti-obesity Medicine Market Size by Region: 2017 VS 2021 VS 2035
        2.2.2 Anti-obesity Medicine Historic Market Size by Region (2017-2022)
        2.2.3 Anti-obesity Medicine Forecasted Market Size by Region (2023-2035)
    2.3 Anti-obesity Medicine Market Dynamics
        2.3.1 Anti-obesity Medicine Industry Trends
        2.3.2 Anti-obesity Medicine Market Drivers
        2.3.3 Anti-obesity Medicine Market Challenges
        2.3.4 Anti-obesity Medicine Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Anti-obesity Medicine Players by Revenue
        3.1.1 Global Top Anti-obesity Medicine Players by Revenue (2017-2022)
        3.1.2 Global Anti-obesity Medicine Revenue Market Share by Players (2017-2022)
    3.2 Global Anti-obesity Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Anti-obesity Medicine Revenue
    3.4 Global Anti-obesity Medicine Market Concentration Ratio
        3.4.1 Global Anti-obesity Medicine Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Anti-obesity Medicine Revenue in 2021
    3.5 Anti-obesity Medicine Key Players Head office and Area Served
    3.6 Key Players Anti-obesity Medicine Product Solution and Service
    3.7 Date of Enter into Anti-obesity Medicine Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-obesity Medicine Breakdown Data by Type
    4.1 Global Anti-obesity Medicine Historic Market Size by Type (2017-2022)
    4.2 Global Anti-obesity Medicine Forecasted Market Size by Type (2023-2035)
5 Anti-obesity Medicine Breakdown Data by Application
    5.1 Global Anti-obesity Medicine Historic Market Size by Application (2017-2022)
    5.2 Global Anti-obesity Medicine Forecasted Market Size by Application (2023-2035)
6 North America
    6.1 North America Anti-obesity Medicine Market Size (2017-2035)
    6.2 North America Anti-obesity Medicine Market Size by Type
        6.2.1 North America Anti-obesity Medicine Market Size by Type (2017-2022)
        6.2.2 North America Anti-obesity Medicine Market Size by Type (2023-2035)
        6.2.3 North America Anti-obesity Medicine Market Share by Type (2017-2035)
    6.3 North America Anti-obesity Medicine Market Size by Application
        6.3.1 North America Anti-obesity Medicine Market Size by Application (2017-2022)
        6.3.2 North America Anti-obesity Medicine Market Size by Application (2023-2035)
        6.3.3 North America Anti-obesity Medicine Market Share by Application (2017-2035)
    6.4 North America Anti-obesity Medicine Market Size by Country
        6.4.1 North America Anti-obesity Medicine Market Size by Country (2017-2022)
        6.4.2 North America Anti-obesity Medicine Market Size by Country (2023-2035)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Anti-obesity Medicine Market Size (2017-2035)
    7.2 Europe Anti-obesity Medicine Market Size by Type
        7.2.1 Europe Anti-obesity Medicine Market Size by Type (2017-2022)
        7.2.2 Europe Anti-obesity Medicine Market Size by Type (2023-2035)
        7.2.3 Europe Anti-obesity Medicine Market Share by Type (2017-2035)
    7.3 Europe Anti-obesity Medicine Market Size by Application
        7.3.1 Europe Anti-obesity Medicine Market Size by Application (2017-2022)
        7.3.2 Europe Anti-obesity Medicine Market Size by Application (2023-2035)
        7.3.3 Europe Anti-obesity Medicine Market Share by Application (2017-2035)
    7.4 Europe Anti-obesity Medicine Market Size by Country
        7.4.1 Europe Anti-obesity Medicine Market Size by Country (2017-2022)
        7.4.2 Europe Anti-obesity Medicine Market Size by Country (2023-2035)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Anti-obesity Medicine Market Size (2017-2035)
    8.2 Asia-Pacific Anti-obesity Medicine Market Size by Type
        8.2.1 Asia-Pacific Anti-obesity Medicine Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Anti-obesity Medicine Market Size by Type (2023-2035)
        8.2.3 Asia-Pacific Anti-obesity Medicine Market Share by Type (2017-2035)
    8.3 Asia-Pacific Anti-obesity Medicine Market Size by Application
        8.3.1 Asia-Pacific Anti-obesity Medicine Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Anti-obesity Medicine Market Size by Application (2023-2035)
        8.3.3 Asia-Pacific Anti-obesity Medicine Market Share by Application (2017-2035)
    8.4 Asia-Pacific Anti-obesity Medicine Market Size by Region
        8.4.1 Asia-Pacific Anti-obesity Medicine Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Anti-obesity Medicine Market Size by Region (2023-2035)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Anti-obesity Medicine Market Size (2017-2035)
    9.2 Latin America Anti-obesity Medicine Market Size by Type
        9.2.1 Latin America Anti-obesity Medicine Market Size by Type (2017-2022)
        9.2.2 Latin America Anti-obesity Medicine Market Size by Type (2023-2035)
        9.2.3 Latin America Anti-obesity Medicine Market Share by Type (2017-2035)
    9.3 Latin America Anti-obesity Medicine Market Size by Application
        9.3.1 Latin America Anti-obesity Medicine Market Size by Application (2017-2022)
        9.3.2 Latin America Anti-obesity Medicine Market Size by Application (2023-2035)
        9.3.3 Latin America Anti-obesity Medicine Market Share by Application (2017-2035)
    9.4 Latin America Anti-obesity Medicine Market Size by Country
        9.4.1 Latin America Anti-obesity Medicine Market Size by Country (2017-2022)
        9.4.2 Latin America Anti-obesity Medicine Market Size by Country (2023-2035)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Anti-obesity Medicine Market Size (2017-2035)
    10.2 Middle East & Africa Anti-obesity Medicine Market Size by Type
        10.2.1 Middle East & Africa Anti-obesity Medicine Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Anti-obesity Medicine Market Size by Type (2023-2035)
        10.2.3 Middle East & Africa Anti-obesity Medicine Market Share by Type (2017-2035)
    10.3 Middle East & Africa Anti-obesity Medicine Market Size by Application
        10.3.1 Middle East & Africa Anti-obesity Medicine Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Anti-obesity Medicine Market Size by Application (2023-2035)
        10.3.3 Middle East & Africa Anti-obesity Medicine Market Share by Application (2017-2035)
    10.4 Middle East & Africa Anti-obesity Medicine Market Size by Country
        10.4.1 Middle East & Africa Anti-obesity Medicine Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Anti-obesity Medicine Market Size by Country (2023-2035)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Alizyme
        11.1.1 Alizyme Company Details
        11.1.2 Alizyme Business Overview
        11.1.3 Alizyme Anti-obesity Medicine Introduction
        11.1.4 Alizyme Revenue in Anti-obesity Medicine Business (2017-2022)
        11.1.5 Alizyme Recent Developments
    11.2 Amylin Pharmaceuticals
        11.2.1 Amylin Pharmaceuticals Company Details
        11.2.2 Amylin Pharmaceuticals Business Overview
        11.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Introduction
        11.2.4 Amylin Pharmaceuticals Revenue in Anti-obesity Medicine Business (2017-2022)
        11.2.5 Amylin Pharmaceuticals Recent Developments
    11.3 Arena Pharmaceuticals
        11.3.1 Arena Pharmaceuticals Company Details
        11.3.2 Arena Pharmaceuticals Business Overview
        11.3.3 Arena Pharmaceuticals Anti-obesity Medicine Introduction
        11.3.4 Arena Pharmaceuticals Revenue in Anti-obesity Medicine Business (2017-2022)
        11.3.5 Arena Pharmaceuticals Recent Developments
    11.4 Boehringer Ingelheim
        11.4.1 Boehringer Ingelheim Company Details
        11.4.2 Boehringer Ingelheim Business Overview
        11.4.3 Boehringer Ingelheim Anti-obesity Medicine Introduction
        11.4.4 Boehringer Ingelheim Revenue in Anti-obesity Medicine Business (2017-2022)
        11.4.5 Boehringer Ingelheim Recent Developments
    11.5 Eisai
        11.5.1 Eisai Company Details
        11.5.2 Eisai Business Overview
        11.5.3 Eisai Anti-obesity Medicine Introduction
        11.5.4 Eisai Revenue in Anti-obesity Medicine Business (2017-2022)
        11.5.5 Eisai Recent Developments
    11.6 GlaxoSmithKline
        11.6.1 GlaxoSmithKline Company Details
        11.6.2 GlaxoSmithKline Business Overview
        11.6.3 GlaxoSmithKline Anti-obesity Medicine Introduction
        11.6.4 GlaxoSmithKline Revenue in Anti-obesity Medicine Business (2017-2022)
        11.6.5 GlaxoSmithKline Recent Developments
    11.7 Orexigen Therapeutics
        11.7.1 Orexigen Therapeutics Company Details
        11.7.2 Orexigen Therapeutics Business Overview
        11.7.3 Orexigen Therapeutics Anti-obesity Medicine Introduction
        11.7.4 Orexigen Therapeutics Revenue in Anti-obesity Medicine Business (2017-2022)
        11.7.5 Orexigen Therapeutics Recent Developments
    11.8 Vivus
        11.8.1 Vivus Company Details
        11.8.2 Vivus Business Overview
        11.8.3 Vivus Anti-obesity Medicine Introduction
        11.8.4 Vivus Revenue in Anti-obesity Medicine Business (2017-2022)
        11.8.5 Vivus Recent Developments
    11.9 Pfizer
        11.9.1 Pfizer Company Details
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Anti-obesity Medicine Introduction
        11.9.4 Pfizer Revenue in Anti-obesity Medicine Business (2017-2022)
        11.9.5 Pfizer Recent Developments
    11.10 Roche
        11.10.1 Roche Company Details
        11.10.2 Roche Business Overview
        11.10.3 Roche Anti-obesity Medicine Introduction
        11.10.4 Roche Revenue in Anti-obesity Medicine Business (2017-2022)
        11.10.5 Roche Recent Developments
    11.11 Merck
        11.11.1 Merck Company Details
        11.11.2 Merck Business Overview
        11.11.3 Merck Anti-obesity Medicine Introduction
        11.11.4 Merck Revenue in Anti-obesity Medicine Business (2017-2022)
        11.11.5 Merck Recent Developments
    11.12 Novo Nordisk
        11.12.1 Novo Nordisk Company Details
        11.12.2 Novo Nordisk Business Overview
        11.12.3 Novo Nordisk Anti-obesity Medicine Introduction
        11.12.4 Novo Nordisk Revenue in Anti-obesity Medicine Business (2017-2022)
        11.12.5 Novo Nordisk Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Anti-obesity Medicine Market